Haematology
Haematology
2022-06-15T00:00:00.000+01:00
Ongoing
MK-1026-003
MK-1026-003
Haematology
A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study
A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study
Trial overview
Description
A Phase 2/3, Randomized, Open-Label Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Study details
For detailed information on this trial, please click here.
Trial status
Recruiting
Priniciple Investigator
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.